If there is one book to have it is camping and Woodcraft by Horace Kephart. I have used this book for over 5o years.
https://www.amazon.com/Book-Camping-Woodcraft-Legacy-Wilderness/dp/1643890034/ref=sr_1_1_sspa?crid=40M17Z5X7GC9&dchild=1&keywords=camping+and+woodcraft+by+horace+kephart&qid=1594082110&s=books&sprefix=camping+and+woodcraft%2Cstripbooks%2C193&sr=1-1-spons&psc=1&spLa=ZW5jcnlwdGVkUXVhbGlmaWVyPUEyRVA5QTVUSjhTOVM2JmVuY3J5cHRlZElkPUExMDE2OTk1MjVGSU9aWDlUMjdSMSZlbmNyeXB0ZWRBZElkPUEwMDA0MTEyMkhPN0hSNlpETUtGNiZ3aWRnZXROYW1lPXNwX2F0ZiZhY3Rpb249Y2xpY2tSZWRpcmVjdCZkb05vdExvZ0NsaWNrPXRydWU=
Recently made my first ever batch - fabulously tasty! So many plant greens are edible… to think all these years I have been discarding so much good and highly nutritious food!
David: thanks for the foraging books info - I ordered a couple of them today! Also thanks for the kale crackers recipe. Kale grows so well here, year round, and I too was frustrated with the fragility of kale chips. This will be much more substantial as well as customizable to taste.
You are welcome westcoastjan. I first devised my kale cracker recipe by looking at the ingredients on a package of expensive and fragile kale chips, thinking I could make something more hearty and substantial. 
I should try some carrot top pesto. I bet carrot tops would go good in a kale cracker mix too…
This is how we develop a new food culture, devising and sharing ways to utilize this wild goodness (or garden goodness) instead of relying on recipes that call for “one can of _____” from the grocery store.
Great points about potential natural disasters coinciding with pandemic waves.
Another (non-natural) disaster the vaccine mafia are threatening with worldwide is flu shots (filled with hypertoxic heavy metals, detergents, corrosives, embalming fluid, animal organ tissues with their own microbe population, etc) given especially to elderly populations, which obliterate the immune system leaving one far more vulnerable to HB-19 and other pathogens.
Avoiding adjuvanted/trojan-horsed vaccines should likely be #2 after optimizing vitamin D levels (60-80 ng/ml or at the very least 40+).
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31483-5/
Methods
35 883 households were selected from municipal rolls using two-stage random sampling stratified by province and municipality size, with all residents invited to participate. From April 27 to May 11, 2020, 61 075 participants (75·1% of all contacted individuals within selected households) answered a questionnaire on history of symptoms compatible with COVID-19 and risk factors, received a point-of-care antibody test, and, if agreed, donated a blood sample for additional testing with a chemiluminescent microparticle immunoassay. Prevalences of IgG antibodies were adjusted using sampling weights and post-stratification to allow for differences in non-response rates based on age group, sex, and census-tract income. Using results for both tests, we calculated a seroprevalence range maximising either specificity (positive for both tests) or sensitivity (positive for either test).
Findings
Seroprevalence was 5·0% (95% CI 4·7–5·4) by the point-of-care test and 4·6% (4·3–5·0) by immunoassay, with a specificity–sensitivity range of 3·7% (3·3–4·0; both tests positive) to 6·2% (5·8–6·6; either test positive), with no differences by sex and lower seroprevalence in children younger than 10 years (<3·1% by the point-of-care test). There was substantial geographical variability, with higher prevalence around Madrid (>10%) and lower in coastal areas (<3%). Seroprevalence among 195 participants with positive PCR more than 14 days before the study visit ranged from 87·6% (81·1–92·1; both tests positive) to 91·8% (86·3–95·3; either test positive). In 7273 individuals with anosmia or at least three symptoms, seroprevalence ranged from 15·3% (13·8–16·8) to 19·3% (17·7–21·0). Around a third of seropositive participants were asymptomatic, ranging from 21·9% (19·1–24·9) to 35·8% (33·1–38·5). Only 19·5% (16·3–23·2) of symptomatic participants who were seropositive by both the point-of-care test and immunoassay reported a previous PCR test.
[embed]https://www.youtube.com/watch?time_continue=28&v=5btuLp-SJn4&feature=emb_logo[/embed]
This should be interesting